94 related articles for article (PubMed ID: 8297144)
1. Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line.
Boccuzzi G; Di Monaco M; Brignardello E; Leonardi L; Gatto V; Pizzini A; Gallo M
Anticancer Res; 1993; 13(6A):2267-72. PubMed ID: 8297144
[TBL] [Abstract][Full Text] [Related]
2. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool.
Toth-Fejel S; Cheek J; Calhoun K; Muller P; Pommier RF
Arch Surg; 2004 Jan; 139(1):50-4. PubMed ID: 14718276
[TBL] [Abstract][Full Text] [Related]
4. Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol.
Boccuzzi G; Brignardello E; di Monaco M; Forte C; Leonardi L; Pizzini A
Anticancer Res; 1992; 12(3):799-803. PubMed ID: 1535770
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
6. DHEA-induced antiproliferative effect in MCF-7 cells is androgen- and estrogen receptor-independent.
Gayosso V; Montano LF; López-Marure R
Cancer J; 2006; 12(2):160-5. PubMed ID: 16630408
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid hormone modulation of NADPH pathways in MCF-7 cells.
Thomas M; Bader C; Monet JD
Cancer Res; 1990 Feb; 50(4):1195-200. PubMed ID: 2297768
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
9. In vitro response of human breast cancer cell lines to the growth-inhibitory effects of styrylpyrone derivative (SPD) and assessment of its antiestrogenicity.
Hawariah A; Stanslas J
Anticancer Res; 1998; 18(6A):4383-6. PubMed ID: 9891496
[TBL] [Abstract][Full Text] [Related]
10. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
12. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
[TBL] [Abstract][Full Text] [Related]
16. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effect of 1,25-dihydroxyvitamin D3 on the glucose-6-phosphate dehydrogenase activity in the MCF-7 human breast cancer cell line.
Noun A; Garabedian M; Monet JD
Cell Biochem Funct; 1989 Jan; 7(1):1-6. PubMed ID: 2752532
[TBL] [Abstract][Full Text] [Related]
18. Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action.
Di Monaco M; Leonardi L; Gatto V; Gallo M; Brignardello E; Boccuzzi G
Anticancer Res; 1995; 15(6B):2581-4. PubMed ID: 8669827
[TBL] [Abstract][Full Text] [Related]
19. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
[TBL] [Abstract][Full Text] [Related]
20. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
Pihie AH; Stanslas J; Din LB
Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
